Blood Tests for Diabetes: What to Monitor and When
Managing diabetes requires tracking more than just blood sugar. This guide covers every blood test used for diabetes monitoring — HbA1c, kidney function, lipids, and micronutrients — with the target ranges used in US clinical practice.
Upload your blood test PDF and get a free scored health breakdown.
Get My Score →The Core Diabetes Monitoring Panel
Type 2 diabetes affects around 37 million Americans. The condition requires regular blood testing not just to track glucose control, but because diabetes damages multiple organ systems simultaneously — kidneys, eyes, nerves, and blood vessels. The monitoring panel covers all of these.
| Test | Target for Diabetics | Frequency |
|---|---|---|
| HbA1c | Below 7.0% (individualised) | Every 3 months until stable, then every 6 months |
| Fasting glucose | 80–130 mg/dL | As directed / self-monitoring |
| eGFR (kidney function) | Above 60 mL/min/1.73m² | Annually |
| Urine albumin-to-creatinine ratio | Below 30 mg/g | Annually |
| LDL cholesterol | Below 100 mg/dL (below 70 if CVD present) | Annually |
| Triglycerides | Below 150 mg/dL | Annually |
| Vitamin B12 (if on metformin) | Above 300 pg/mL | Annually |
Tests That Reveal the Full Picture
HbA1c: The Central Measure
HbA1c reflects average blood glucose over the past 2–3 months by measuring what percentage of haemoglobin has glucose attached. The American Diabetes Association target is below 7.0% for most adults with diabetes, with individualisation based on age, hypoglycaemia risk, and complications. Every 1% reduction in HbA1c reduces microvascular complications (kidney disease, retinopathy, neuropathy) by approximately 25–35% in clinical trials.
Kidney Monitoring Is Not Optional
Diabetic kidney disease (diabetic nephropathy) is the leading cause of kidney failure in the US. eGFR and the urine albumin-to-creatinine ratio (uACR) together detect it at a stage where progression can be significantly slowed. eGFR measures filtering capacity; uACR detects protein leaking into urine — the earliest sign of kidney damage. Both should be tested annually even in people with well-controlled diabetes and currently normal kidney function.
Lipids and Cardiovascular Risk
Diabetes doubles to quadruples cardiovascular risk, making lipid management central. LDL targets for diabetics are stricter than the general population — below 100 mg/dL, or below 70 mg/dL in people with existing cardiovascular disease. Annual lipid panels assess the effectiveness of dietary changes and statin therapy. ApoB testing adds further precision, particularly in people with metabolic syndrome and small dense LDL.
Pre-Diabetes Warning Signs to Watch
Metformin and B12 Depletion
Metformin — the most commonly prescribed diabetes medication — reduces intestinal B12 absorption by up to 30% through its effects on the intrinsic factor-B12 receptor in the gut. Approximately 10–30% of long-term metformin users develop B12 deficiency. Annual B12 testing should be routine for anyone on metformin — particularly as B12 deficiency causes peripheral neuropathy that can be mistaken for diabetic neuropathy.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Reference ranges, supplement dosages, and nutritional information mentioned are general educational guidance from published research—not personalised recommendations. Do not use this content to self-diagnose or self-treat any condition. Always consult a qualified healthcare provider before making any changes to your health regimen, medications, or supplements.
See exactly where your results stand
Upload your blood test PDF and get a free A–F score across all 6 health domains in seconds.
Analyze My Blood Test →